Recent Posts
- Illinois Attorney General Files Lawsuit Against HIV/AIDS Nonprofit
- California Gov. Arnold Schwarzenegger Signs Budget That Cuts $52M From HIV/AIDS Programs
- Efforts Underway In Namibia To Treat Pediatric HIV
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Also In Global Health News: Uganda Male Circumcision; Malaria Vaccine; Potential Global Fund Grant In Cambodia; PMTCT Of HIV In Botswana
Random Posts
- National AIDS Fund Lauds Initiative To Remove Ban On Federal Funding For Syringe Exchange Programs
- WFP Appeals For $5.2M To Feed At Least 500,000 Malawaians Through Dec. 2010
- Cancer-Causing Virus Associated With Higher Risk Of New HIV Infection
- New HIV Recommendations To Improve Health, Reduce Infections And Save Lives
- News Outlets Continue To Examine Findings Of U.N. HIV/AIDS Progress Report
- Denver Post Examines Efforts To Establish Needle-Exchange Programs In Colorado
- Social, Sexual Barriers Faced By Black Gay Men Could Influence HIV Risk, Prevalence, Study Says
- New Survey Targets Over 50s Living With HIV, UK
- HIV/AIDS Education Project Targeting Pennsylvania Black Women Examined
- Viriom Selects ChemDiv To Develop HIV Program
Prescription AIDS Drugs
Contact Us
The reason deadly infections like human immunodeficiency virus (HIV) and hepatitis C never go away is because these viruses disarm the body’s defense system. Researchers at the University of Alabama at Birmingham (UAB) have discovered that a key immunity protein must be present for this defense system to have a chance against chronic infection.
Research up to now has tried but failed to decipher the cross-talk between ‘killer T-cells’ and ‘helper T-cells’ in the fight against viruses. The new UAB study finds this cross-talk can only happen in the presence of interleukin-21, a powerful immune system protein. If interleukin-21 is missing for whatever reason, then the immune system’s anti-viral efforts fail, said Allan Zajac, Ph.D., an associate professor in UAB’s Department of Microbiology and lead author on the study.
The findings are published in the journal Science through its Science Express service.
“Adding interleukin-21 back in stimulates the immune response and controls the infection,” Zajac said. “We demonstrate that the loss of this protein prevents the control of the infection and diminishes the function of the killer T-cells, specifically CD8 T-cells.”
The study mice were treated for lymphocytic choriomeningitis, a viral infection of the membranes surrounding the brain and spinal cord. Measurements were taken for two types of T-cells, CD4 and CD8 T-cells, before and after the mice were treated with interleukin-21.
“Interleukin-21 served as the key messenger between the T-cells, whereas before we didn’t know exactly how the two types of cells communicated with each other,” Zajac said. The CD4 T-cells help the immune system do its job by boosting CD8 T-cells’ ability to fight and kill viruses.
Co-authors on the study include John Yi and Ming Du, Ph.D., both of UAB’s Department of Microbiology. Research funds came from the National Institutes of Health.
Source:
Troy Goodman
University of Alabama at Birmingham
Related posts:
- How Key Protein Keeps Chronic Infection In Check Why is the immune system able to fight off some...
- Key To Strengthening Immune Response To Chronic Infection Discovered By Wistar Scientists A team of researchers from The Wistar Institute has identified...
- ‘Natural Killer’ Cells Keep Immune System In Balance Natural killer, or NK cells, are part of our...
- How HIV Cripples Immune Cells In order to be able to ward off disease pathogens,...
- Researchers Induce HIV-Neutralizing Antibodies That Recognize HIV-1 Envelope Protein, Lipids For the first time, researchers have experimentally induced antibodies that...
Related posts brought to you by Yet Another Related Posts Plugin.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.